Skip to content
GenomarkerEARLY ACCESS
Log in

Request access

Request early access.

We're onboarding investors, research teams and AI-science platforms in small cohorts, so every early analysis sharpens the checks. A person reads every request.

  • Investors and BD teams get Diligence: independent review of the computational claims behind a deal.
  • Research teams get supported analyses with the checks built in, and a signed record of every run.
  • Platforms and agent builders get early access to the Assurance API developer preview (mid-2027).

REQUESTS REVIEWED WITHIN 5 BUSINESS DAYS
EARLY ACCESS · ONBOARDING IN SMALL COHORTS

Tell us about your work

Everything here helps us route your request to the right surface — Diligence, Runtime or the Assurance API.

Research teamPlatform / agent builderDiligence / investorOther
Reviewed by a human. We reply either way.